Cargando…

Metabolic Syndrome And Lifestyle Factors In Patients With Schizophrenia-A Cross Sectional Hospital Based Study

BACKGROUND: Patients with schizophrenia are more likely to develop cardiovascular diseases like Myocardial infarction, Stroke which result in premature deaths. The increased prevalence of these risk factors can be attributed to several reasons like physical inactivity, poor diet, substance use and t...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129633/
http://dx.doi.org/10.4103/0019-5545.341782
_version_ 1784712803094888448
collection PubMed
description BACKGROUND: Patients with schizophrenia are more likely to develop cardiovascular diseases like Myocardial infarction, Stroke which result in premature deaths. The increased prevalence of these risk factors can be attributed to several reasons like physical inactivity, poor diet, substance use and treatment with second generation antipsychotics. There is paucity of studies on metabolic syndrome and its association lifestyle risk factors in LAMIC nations. AIMS: This study was aimed to estimate the prevalence of metabolic syndrome as per NCEP ATP III criteria and to assess association in relation to sociodemographic, clinical and lifestyle related variables. METHODS: A cross sectional study design was employed. All consecutive patients with DSM-5 diagnosis of Schizophrenia in the age group of 18 -65 years were enrolled in the study after obtaining written informed consent. Statistical analysis was done using software SPSS Version 20. The demographic and clinical data are presented in frequencies, mean and standard deviation. The chi square test was used to assess the significance of associations between categorical variables. RESULTS: The prevalence of metabolic syndrome is 41 % in patients with Schizophrenia in urban hospital setting. Majority of patients reported low-moderate intensity physical activity, low fiber intake and high fat intake. This study had shown positive association of metabolic syndrome with female gender after adjusting other variables found in univariate analysis. CONCLUSIONS: The burden of cardio metabolic risk factors in patients with Schizophrenia is quite high. There is need for early screening and effective intervention to decrease morbidity and mortality in patients with Schizophrenia.
format Online
Article
Text
id pubmed-9129633
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91296332022-05-25 Metabolic Syndrome And Lifestyle Factors In Patients With Schizophrenia-A Cross Sectional Hospital Based Study Indian J Psychiatry Free Papers Compiled BACKGROUND: Patients with schizophrenia are more likely to develop cardiovascular diseases like Myocardial infarction, Stroke which result in premature deaths. The increased prevalence of these risk factors can be attributed to several reasons like physical inactivity, poor diet, substance use and treatment with second generation antipsychotics. There is paucity of studies on metabolic syndrome and its association lifestyle risk factors in LAMIC nations. AIMS: This study was aimed to estimate the prevalence of metabolic syndrome as per NCEP ATP III criteria and to assess association in relation to sociodemographic, clinical and lifestyle related variables. METHODS: A cross sectional study design was employed. All consecutive patients with DSM-5 diagnosis of Schizophrenia in the age group of 18 -65 years were enrolled in the study after obtaining written informed consent. Statistical analysis was done using software SPSS Version 20. The demographic and clinical data are presented in frequencies, mean and standard deviation. The chi square test was used to assess the significance of associations between categorical variables. RESULTS: The prevalence of metabolic syndrome is 41 % in patients with Schizophrenia in urban hospital setting. Majority of patients reported low-moderate intensity physical activity, low fiber intake and high fat intake. This study had shown positive association of metabolic syndrome with female gender after adjusting other variables found in univariate analysis. CONCLUSIONS: The burden of cardio metabolic risk factors in patients with Schizophrenia is quite high. There is need for early screening and effective intervention to decrease morbidity and mortality in patients with Schizophrenia. Wolters Kluwer - Medknow 2022-03 2022-03-24 /pmc/articles/PMC9129633/ http://dx.doi.org/10.4103/0019-5545.341782 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Free Papers Compiled
Metabolic Syndrome And Lifestyle Factors In Patients With Schizophrenia-A Cross Sectional Hospital Based Study
title Metabolic Syndrome And Lifestyle Factors In Patients With Schizophrenia-A Cross Sectional Hospital Based Study
title_full Metabolic Syndrome And Lifestyle Factors In Patients With Schizophrenia-A Cross Sectional Hospital Based Study
title_fullStr Metabolic Syndrome And Lifestyle Factors In Patients With Schizophrenia-A Cross Sectional Hospital Based Study
title_full_unstemmed Metabolic Syndrome And Lifestyle Factors In Patients With Schizophrenia-A Cross Sectional Hospital Based Study
title_short Metabolic Syndrome And Lifestyle Factors In Patients With Schizophrenia-A Cross Sectional Hospital Based Study
title_sort metabolic syndrome and lifestyle factors in patients with schizophrenia-a cross sectional hospital based study
topic Free Papers Compiled
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129633/
http://dx.doi.org/10.4103/0019-5545.341782